Literature DB >> 15582656

Evidence for a direct interaction between HSV-1 ICP27 and ICP8 proteins.

Melanie Olesky1, Elizabeth E McNamee, Changhong Zhou, Travis J Taylor, David M Knipe.   

Abstract

Herpes simplex virus 1 (HSV-1) ICP27 and ICP8 proteins have both been implicated in the transcription of late genes and regulation of viral gene expression. We showed previously that ICP27 and ICP8 associate with the RNAP II holoenzyme (Zhou and Knipe, J. Virol. 76, 5893-5904). Here, we demonstrate that ICP27 and ICP8 coprecipitate from lysates of HSV-1-infected HEp2 cells and from lysates of insect cells expressing ICP27 and ICP8, the latter being in the absence of other HSV-1 proteins. By expressing and purifying hexahistidine-tagged ICP8 (His-ICP8) and maltose binding protein (MBP)-tagged ICP27 (MBP-27) proteins and performing in vitro immunoprecipitation and pull-down assays, we also demonstrate that ICP27 and ICP8 coprecipitate in the absence of other viral or cellular proteins. Taken together, these data provide evidence that ICP27 and ICP8 interact directly in vitro and in infected cells. We hypothesize that the ICP27-ICP8 interaction plays a role in the stimulation of late gene transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582656     DOI: 10.1016/j.virol.2004.10.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.

Authors:  Karen E Johnson; David M Knipe
Journal:  Virology       Date:  2009-10-31       Impact factor: 3.616

2.  Herpes simplex virus 1 regulatory protein ICP27 undergoes a head-to-tail intramolecular interaction.

Authors:  Felicia P Hernandez; Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

3.  ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection.

Authors:  Jenny Q Dai-Ju; Ling Li; Lisa A Johnson; Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling.

Authors:  Karen E Johnson; Byeongwoon Song; David M Knipe
Journal:  Virology       Date:  2008-02-14       Impact factor: 3.616

5.  Direct stimulation of translation by the multifunctional herpesvirus ICP27 protein.

Authors:  Osmany Larralde; Richard W P Smith; Gavin S Wilkie; Poonam Malik; Nicola K Gray; J Barklie Clements
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  The structure of the folded domain from the signature multifunctional protein ICP27 from herpes simplex virus-1 reveals an intertwined dimer.

Authors:  Richard B Tunnicliffe; Mitchell Schacht; Colin Levy; Thomas A Jowitt; Rozanne M Sandri-Goldin; Alexander P Golovanov
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

7.  Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expression.

Authors:  Jason P Roth; Joseph K-K Li; John D Morrey; Dale L Barnard; Almut H Vollmer
Journal:  Virus Genes       Date:  2013-05-18       Impact factor: 2.198

8.  Role for A-type lamins in herpesviral DNA targeting and heterochromatin modulation.

Authors:  Lindsey Silva; Anna Cliffe; Lynne Chang; David M Knipe
Journal:  PLoS Pathog       Date:  2008-05-23       Impact factor: 6.823

9.  An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription.

Authors:  Reza Djavadian; Ya-Fang Chiu; Eric Johannsen
Journal:  PLoS Pathog       Date:  2016-06-27       Impact factor: 6.823

Review 10.  Herpesvirus Late Gene Expression: A Viral-Specific Pre-initiation Complex Is Key.

Authors:  Henri Gruffat; Roberta Marchione; Evelyne Manet
Journal:  Front Microbiol       Date:  2016-06-06       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.